So in EMCrit 308 – Risk Stratification and Treatment of Pulmonary Embolism (PE) 2021 Is the PERT Wilted, I discussed my vision of PERT Teams. The plan was to bring together a group of experts to discuss the episode and point out what I got right and what I got wrong.
The Panelists
Geoffrey Barnes, MD, MSc
Assistant Professor of Internal Medicine
Vascular and Cardiovascular Medicine
Director, Vascular Medicine Fellowship
Director, PERT
Frankel Cardiovascular Center
Co-Director, Michigan Program on Value Enhancement (MPrOVE)
Holder of the James O Wolliscroft Early Career Endowment Award
University of Michigan
COI
Consulting – Pfizer/Bristol-Myers Squib, Jansen, Acelis Connected Health
Site PI – HI-PEITHO trial (Boston Scientific)
Board of Directors – Anticoagulation Forum
F. Mae West
Co-Director PERT Team
Thomas Jefferson Hospital
COI
Steering Committee – STRIKE-PE (Penumbra)
Sub-Investigator – FLASH (Inari)
Jim Horowitz
The Discussion
-
What is the Optimal Use of a PERT Team? 6:09.009
-
Is there a benefit of CDT over Peripheral? 13:23.251
-
Anticoag while Lysing? 20:58.937
-
What is the State of Catheter Thrombectomy and Embolectomy Devices? 25:46.840
-
What about Hospitals that don't Have PERT Teams or Fancy Options 33:10.400
-
Industry funding of PERT Teams and Orgs. 36:08.594
References
- Effect of a Multidisciplinary Pulmonary Embolism Response Team on Patient Mortality PMID: 34794606
Now on to the Wee…
You Need an EMCrit Membership to see this content. Login here if you already have one.
- EMCrit 373 – Mike Weinstock with another Critical Care Bounceback: “Asymptomatic Hypertension” - April 18, 2024
- EMCrit Wee – Ross Prager on 10 Heuristics for the New ICU Attending - April 13, 2024
- EMCrit 372 – FoundStab Intubation SOP - April 5, 2024
very cool Scott.. you brought us three super docs from U of M, Tom Jeff and NYU to discuss an incredibly important subject. you moderated well, cool discussion. PE’s scare me immensely.
tom fiero